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Fig 3: A2780, OVCAR3, and HEYA8 cells lines were 
incubated in a hypoxia chamber for 24 hours. RNA was 
extracted via a Trizol RNA extraction. Quantitative PCR 
was performed with the hypoxic RNA compared to RNA 
extracted from cells cultured in normoxia. Beta actin 
primers were used as an endogenous positive control. 
The experiment was repeated three times. * p < 0.05 
* 
Fig 5: A real time proliferation assay was performed using 
the xCELLigence system. Transfected HEYA8 cells were 
plated at 5000 cells/well in xCELLigence e-plates in 100μl 
of RPMI media. Proliferation was measured in the system 
for 72 hours at 37°C in 5% CO2. The experiment was 
repeated three times. Data from a representative 
experiment.  
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Ovarian carcinoma is a highly metastatic cancer that is often 
diagnosed at an advanced stage. As ovarian cancer develops it 
metastasizes into the peritoneal cavity, where tumors invade the 
mesothelium.1 Here tumors encounter a hypoxic microenvironment 
due to irregular vascularization and stagnant ascites fluid. 
Microenvironment stress promotes tumors to initiate angiogenesis, 
the formation of new blood vessels, in order to access oxygen and 
nutrients from the blood. Further understanding hypoxia-induced 
angiogenesis is critical for improving patient treatment and 
identifying novel pharmacological targets. Previous work in our 
laboratory has identified the Maturin protein as a target of interest in 
the hypoxic response of ovarian carcinoma. Maturin is translated 
from a highly conserved gene named MTURN. The protein is 
uncharacterized in ovarian carcinoma. We hypothesize that Maturin 
is involved in the hypoxic response of ovarian carcinoma. To test the 
hypothesis we quantified MTURN expression under hypoxic stress 
in A2780, HEYA8, and OVCAR3 cell lines. Furthermore, the Maturin 
phenotype was investigated in vitro using an shRNA knockdown 
vector in HEYA8 cells. Our results indicate that MURN expression is 
up regulated in hypoxia, in vitro knockdown of the gene modulates 
cell proliferation and sensitizes cells to carboplatin treatment. 
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Future Studies 
•  MTURN expression is up regulated in response to 
hypoxia in HEYA8, A2780, and OVCAR3 cell lines 
•  MTURN knockdown via shRNA reduces HEYA8 
proliferation rate in vitro  
•  MTURN knockdown via shRNA sensitizes HEYA8 
cells to carboplatin treatment 
•  Effect of MTURN knockdown on cell cycle 
•  Western blot protein expression verification 
•  Characterization of MTURN expression in mouse 
tumor models 
•  Further drug sensitization screening 
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Fig 4: Transfected HEYA8 cells were plated in a 96 
well plate at 5000cells/well in 100μl!of RPMI media. 
Cells were incubated 12 hours at 37°C in 5% CO2 
and treated with carboplatin in doses ranging from 
1&200μM. After treatment cells were incubated for 48 
hours. A MTT Assay was performed and the 590nm 
absorbance was measured using a plate reader. IC50 
of carboplatin concentration was calculated from the 
concentration response curve. 
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